Seeking Alpha

Lively debate on Star Scientific

  • The situation at Star Scientific (STSI +0.9%) is bleak, according to SA contributor Paulo Santos.
  • He thinks the company's desperate measure to raise capital through the issuance of new shares is just buying time with hopes for a revenue bonanza fading.
  • The bull case on STSI hinges on the potential for Anatabloc to be a mass market product. The company expects a patent related to the treatment's active ingredient to be granted shortly.
Comments (1)
  • I wouldn't be holding my breath.
    16 Oct 2013, 10:03 PM Reply Like
DJIA (DIA) S&P 500 (SPY)